Chengsheng Chen

Chengsheng Chen is a highly experienced scientist with a strong background in chemistry and chemical engineering. Currently serving as a Senior Scientist at Bristol Myers Squibb since January 2024, Chengsheng previously held a Senior Scientist position at Mirati Therapeutics from January 2022 to January 2024. Prior experience includes a role as Chemist I at Boehringer Ingelheim from November 2020 to January 2022, as well as an internship at Boehringer Ingelheim in the summer of 2019. Chengsheng holds a Doctor of Philosophy (PhD) in Chemistry from the University of Connecticut, a Master of Science (MS) in Chemistry from California State University, Fresno, and a Bachelor of Engineering (BE) in Chemical Engineering from Shanghai University.